Literature DB >> 18636307

Evaluation of nitric oxide synthase activity, nitric oxide, and homocysteine levels in patients with active Behcet's disease.

Seyithan Taysi1, Refik Ali Sari, Hakan Dursun, Adnan Yilmaz, Mustafa Keles, Kerim Cayir, Mehmet Akyuz, Abdullah Uyanik, Adem Guvenc.   

Abstract

Behcet's disease (BD) is a chronic, progressive disorder that affects many systems of the body including the eye. The aim of this study was to examine the effects of nitric oxide synthase activity (NOS), nitric oxide (NO*), and homocysteine (Hcy) levels in patients with active BD. Included in this study were 18 male BD patients and 16 male healthy volunteers as controls. Erythrocyte NOS activity, (NO*) erythrocyte sedimentation rate, serum C-reactive protein, and plasma Hcy values in the patients with BD were significantly higher than those of the control group. Our results show that these parameters play a major role in the inflammatory reactions observed in BD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18636307     DOI: 10.1007/s10067-008-0963-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  38 in total

1.  Assessment of homocysteine, neopterin and nitric oxide levels in Behçet's disease.

Authors:  Yeşim Ozkan; Sevgi Yardim-Akaydin; Aylin Sepici; Başak Engin; Vesile Sepici; Bolkan Simşek
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

2.  Serum oxidant/antioxidant status of patients with systemic lupus erythematosus.

Authors:  Seyithan Taysi; Mustafa Gul; Refik Ali Sari; Fatih Akcay; Nuri Bakan
Journal:  Clin Chem Lab Med       Date:  2002-07       Impact factor: 3.694

Review 3.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

4.  The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behçet's disease.

Authors:  K Köse; C Yazici; O Aşşioğlu
Journal:  Clin Biochem       Date:  2001-03       Impact factor: 3.281

5.  Natural killer cell activity in patients with Behćet's disease.

Authors:  K Watanabe; Y Ohashi
Journal:  Am J Ophthalmol       Date:  1984-12-15       Impact factor: 5.258

6.  Clinical features of Behçet's disease in patients in the Sultanate of Oman; the significance of antiphospholipid antibodies?

Authors:  E M El-Ageb; M H Al-Maini; A K Al-Shukaily; Y Al-Farsi; E R Richens
Journal:  Rheumatol Int       Date:  2002-03       Impact factor: 2.631

7.  Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.

Authors:  S Buldanlioglu; S Turkmen; H B Ayabakan; N Yenice; M Vardar; S Dogan; E Mercan
Journal:  Br J Dermatol       Date:  2005-09       Impact factor: 9.302

Review 8.  Nitric oxide and oxygen radicals in infection, inflammation, and cancer.

Authors:  H Maeda; T Akaike
Journal:  Biochemistry (Mosc)       Date:  1998-07       Impact factor: 2.487

9.  Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer.

Authors:  Ebubekir Bakan; Seyithan Taysi; M Fevzi Polat; Sabahattin Dalga; Zuhal Umudum; Nuri Bakan; Metehan Gumus
Journal:  Jpn J Clin Oncol       Date:  2002-05       Impact factor: 3.019

10.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

View more
  5 in total

1.  Influence of corticosteroid therapy on IL-18 and nitric oxide production during Behçet's disease.

Authors:  Fatmazohra Djaballah-Ider; Zineb Djeraba; Mourad Chemli; Nadjiba Dammene-Debbihe; Doulkifly Lounis; Houda Belguendouz; Yanis Medour; Samia Chaib; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2018-03-29       Impact factor: 4.473

2.  A Comparative Metabolomic Evaluation of Behcet's Disease with Arthritis and Seronegative Arthritis Using Synovial Fluid.

Authors:  Joong Kyong Ahn; Sooah Kim; Jungyeon Kim; Jiwon Hwang; Kyoung Heon Kim; Hoon-Suk Cha
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

3.  Expression of TNF-α, APRIL and BCMA in Behcet's disease.

Authors:  Olfat G Shaker; Shereen O Tawfic; Amira M El-Tawdy; Mohamed H M El-Komy; Manal El Menyawi; Ahmed A Heikal
Journal:  J Immunol Res       Date:  2014-11-05       Impact factor: 4.818

4.  Evaluation of Serum Homocysteine and Leptin Levels in Patients with Uveitis.

Authors:  Arif Emre Elbay; Ayşen Topalkara; Ahmet Elbay; Haydar Erdoğan; Ayşe Vural; Abdi Bahadır Çetin
Journal:  Turk J Ophthalmol       Date:  2015-08-05

5.  Serum Vitamin B12, Homocysteine and Methylmalonic Acid Levels in Patients With Parenchymal Neuro-Behçet's Syndrome.

Authors:  Berivan Bitik; Abdurrahman Tufan; Şehri Elbeg; Rıdvan Mercan; Hamit Küçük; Orhan Küçükşahin; Mehmet Akif Öztürk; Seminur Haznedaroğlu; Berna Göker
Journal:  Arch Rheumatol       Date:  2017-02-12       Impact factor: 1.472

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.